Histogen Inc.
HSTO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 310.1% | -55.4% | -82% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 76.1% | 53% | 79.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -278.7% | -1,621.5% | -906% | -24.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -281.8% | -1,626.8% | -911.6% | -99.4% |
| EPS Diluted | -3.46 | -7.51 | -41.6 | -5.02 |
| % Growth | 53.9% | 81.9% | -728.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |